Long COVID
Long COVID refers to a range of symptoms that continue for weeks or months after the initial COVID-19 infection has resolved, affecting various body systems.
Long COVID: Fibroblast Activity Study with [68Ga]FAPI PET/CT
We are investigating if patients with ongoing long COVID symptoms have higher fibroblast activity than those who have recovered. This may help us understand the underlying causes of long-term health issues after COVID-19.
Confirmation phase (III)Monitoring phase (IV)No PlaceboCost ReimbursementInvestigational MedicinesInjectionInternal MedicinePulmonology
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you over 20 years old?
- Have you had trouble breathing or feeling very tired for more than 3 months after a confirmed COVID-19 infection?
- Have you ever had a Fatigue Severity Scale score of 4 or higher?
- Are you able to give informed consent for this study?
- Do you have claustrophobia or feel unable to lie flat for a PET/CT scan?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
FAPI
Tetraazacyclododecane
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
University Medical Center Groningen
Critical Care
Groningen, Netherlands
Sponsor: Universitair Medisch Centrum Groningen
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.